Metformin may curb dementia risk in diabetes patients

07/16/2013 | PhysiciansBriefing.com

A study presented at the Alzheimer's Association International Conference found type 2 diabetes patients treated with metformin had a five-year reduced risk of dementia compared with those on other treatments such as sulfonylureas, thiazolidinediones and insulin. "These results are preliminary evidence that benefits of insulin sensitizers may extend beyond glycemic control to neurocognitive health," researchers wrote.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD